A rating of 76 puts Candel Therapeutics Inc (CADL) near the top of the Biotechnology industry according to InvestorsObserver. Candel Therapeutics Inc's score of 76 means it scores higher than 76% of stocks in the industry. Candel Therapeutics Inc also received an overall rating of 65, putting it above 65% of all stocks. Biotechnology is ranked 19 out of the 148 industries.
CADL has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on CADL!